Why the study?
Is serum exosomal miR-122-5p a useful diagnostic biomarker for acute coronary syndrome and coronary artery stenosis severity?
Is serum exosomal miR-122-5p a useful diagnostic biomarker for acute coronary syndrome and coronary artery stenosis severity?
Serum exosomal miR-122-5p shows potential as a novel diagnostic biomarker for acute coronary syndromes and for predicting coronary lesion severity.
Should not yet change ACS diagnostic practice; leaves open exosomal miR-122-5p utility pending prospective validation.
Serum exosomal miR-122-5p might be useful as a diagnostic biomarker for AMI and UA, and increased serum exosomal miR-122-5p levels could be useful to predict the severity of coronary lesions.
No takes yet. Share an insight, caveat, or question.
Ling et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: